rs143879853

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003803.4(MYOM1):​c.3453T>A​(p.Asp1151Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000965 in 1,613,928 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0054 ( 6 hom., cov: 32)
Exomes 𝑓: 0.00051 ( 7 hom. )

Consequence

MYOM1
NM_003803.4 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.513
Variant links:
Genes affected
MYOM1 (HGNC:7613): (myomesin 1) The giant protein titin, together with its associated proteins, interconnects the major structure of sarcomeres, the M bands and Z discs. The C-terminal end of the titin string extends into the M line, where it binds tightly to M-band constituents of apparent molecular masses of 190 kD (myomesin 1) and 165 kD (myomesin 2). This protein, myomesin 1, like myomesin 2, titin, and other myofibrillar proteins contains structural modules with strong homology to either fibronectin type III (motif I) or immunoglobulin C2 (motif II) domains. Myomesin 1 and myomesin 2 each have a unique N-terminal region followed by 12 modules of motif I or motif II, in the arrangement II-II-I-I-I-I-I-II-II-II-II-II. The two proteins share 50% sequence identity in this repeat-containing region. The head structure formed by these 2 proteins on one end of the titin string extends into the center of the M band. The integrating structure of the sarcomere arises from muscle-specific members of the superfamily of immunoglobulin-like proteins. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008228898).
BP6
Variant 18-3102596-A-T is Benign according to our data. Variant chr18-3102596-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 226818.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00538 (819/152330) while in subpopulation AFR AF= 0.0188 (781/41576). AF 95% confidence interval is 0.0177. There are 6 homozygotes in gnomad4. There are 381 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYOM1NM_003803.4 linkuse as main transcriptc.3453T>A p.Asp1151Glu missense_variant 23/38 ENST00000356443.9 NP_003794.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYOM1ENST00000356443.9 linkuse as main transcriptc.3453T>A p.Asp1151Glu missense_variant 23/381 NM_003803.4 ENSP00000348821 P2P52179-1
MYOM1ENST00000261606.11 linkuse as main transcriptc.3165T>A p.Asp1055Glu missense_variant 22/371 ENSP00000261606 A2P52179-2

Frequencies

GnomAD3 genomes
AF:
0.00537
AC:
817
AN:
152212
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0188
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00382
GnomAD3 exomes
AF:
0.00135
AC:
337
AN:
249120
Hom.:
2
AF XY:
0.000932
AC XY:
126
AN XY:
135142
show subpopulations
Gnomad AFR exome
AF:
0.0196
Gnomad AMR exome
AF:
0.000841
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000266
Gnomad OTH exome
AF:
0.000166
GnomAD4 exome
AF:
0.000506
AC:
739
AN:
1461598
Hom.:
7
Cov.:
30
AF XY:
0.000433
AC XY:
315
AN XY:
727082
show subpopulations
Gnomad4 AFR exome
AF:
0.0184
Gnomad4 AMR exome
AF:
0.000828
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000126
Gnomad4 OTH exome
AF:
0.000977
GnomAD4 genome
AF:
0.00538
AC:
819
AN:
152330
Hom.:
6
Cov.:
32
AF XY:
0.00512
AC XY:
381
AN XY:
74486
show subpopulations
Gnomad4 AFR
AF:
0.0188
Gnomad4 AMR
AF:
0.00189
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00378
Alfa
AF:
0.000834
Hom.:
3
Bravo
AF:
0.00556
ESP6500AA
AF:
0.0176
AC:
67
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00162
AC:
196
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 24, 2014Asp1151Glu in exon 23 of MYOM1: This variant is not expected to have clinical si gnificance because it has been identified in 1.8% (67/3808) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs143879853). -
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsSep 05, 2022This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
MYOM1-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 20, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Hypertrophic cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
17
DANN
Benign
0.87
DEOGEN2
Benign
0.035
T;.;.
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.82
T;T;T
MetaRNN
Benign
0.0082
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.93
L;.;.
MutationTaster
Benign
0.99
D;D;D
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.50
N;.;N
REVEL
Benign
0.073
Sift
Benign
1.0
T;.;T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.0010
B;.;B
Vest4
0.26
MutPred
0.25
Gain of sheet (P = 0.0477);.;.;
MVP
0.56
MPC
0.14
ClinPred
0.0049
T
GERP RS
1.7
Varity_R
0.077
gMVP
0.43

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs143879853; hg19: chr18-3102594; API